Wulffraat N - Search Results

1

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.

Rosé CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Naranjo A, Oliveira-Knupp S, Pajot C, Russo R, Thomée C, Vastert S, Wulffraat N, Arostegui JI, Foley KP, Bertin J, Wouters CH. Rosé CD, et al. Among authors: wulffraat n. Rheumatology (Oxford). 2015 Jun;54(6):1008-16. doi: 10.1093/rheumatology/keu437. Epub 2014 Nov 20. Rheumatology (Oxford). 2015. PMID: 25416713 Free article.

2

Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.

de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, Prakken BJ. de Jager W, et al. Arthritis Rheum. 2009 Sep;60(9):2782-93. doi: 10.1002/art.24750. Arthritis Rheum. 2009. PMID: 19714583 Free article.

3

Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.

Vastert SJ, van Wijk R, D'Urbano LE, de Vooght KM, de Jager W, Ravelli A, Magni-Manzoni S, Insalaco A, Cortis E, van Solinge WW, Prakken BJ, Wulffraat NM, de Benedetti F, Kuis W. Vastert SJ, et al. Rheumatology (Oxford). 2010 Mar;49(3):441-9. doi: 10.1093/rheumatology/kep418. Epub 2009 Dec 17. Rheumatology (Oxford). 2010. PMID: 20019066

4

Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept.

van Dijken TD, Vastert SJ, Gerloni VM, Pontikaki I, Linnemann K, Girschick H, Armbrust W, Minden K, Prince FH, Kokke FT, Nieuwenhuis EE, Horneff G, Wulffraat NM. van Dijken TD, et al. J Rheumatol. 2011 Jul;38(7):1441-6. doi: 10.3899/jrheum.100809. Epub 2011 Apr 1. J Rheumatol. 2011. PMID: 21459936

5

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

Ruperto N, Quartier P, Wulffraat N, Woo P, Ravelli A, Mouy R, Bader-Meunier B, Vastert SJ, Noseda E, D'Ambrosio D, Lecot J, Chakraborty A, Martini A, Chioato A; Paediatric Rheumatology International Clinical Trials Organisation. Ruperto N, et al. Among authors: wulffraat n. Arthritis Rheum. 2012 Feb;64(2):557-67. doi: 10.1002/art.33342. Arthritis Rheum. 2012. PMID: 21953497 Free article. Clinical Trial.

6

Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.

Anink J, Otten MH, Prince FH, Hoppenreijs EP, Wulffraat NM, Swart JF, ten Cate R, van Rossum MA, van den Berg JM, Dolman KM, Koopman-Keemink Y, Armbrust W, Kamphuis S, van Pelt PA, Gorter SL, van Suijlekom-Smit LW. Anink J, et al. Rheumatology (Oxford). 2013 Apr;52(4):712-7. doi: 10.1093/rheumatology/kes373. Epub 2012 Dec 24. Rheumatology (Oxford). 2013. PMID: 23267169

7

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, Dolezalova P, Job-Deslandre C, Wulffraat N, Alvarez D, Zang C, Wajdula J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). Horneff G, et al. Among authors: wulffraat n. Ann Rheum Dis. 2014 Jun;73(6):1114-22. doi: 10.1136/annrheumdis-2012-203046. Epub 2013 May 21. Ann Rheum Dis. 2014. PMID: 23696632 Free PMC article. Clinical Trial.

8

Anti-tumor necrosis factor α targets protein kinase B/c-Akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritis.

Wehrens EJ, Vastert SJ, Mijnheer G, Meerding J, Klein M, Wulffraat NM, Prakken BJ, van Wijk F. Wehrens EJ, et al. Arthritis Rheum. 2013 Dec;65(12):3279-84. doi: 10.1002/art.38132. Arthritis Rheum. 2013. PMID: 23983021 Free article.

9

Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis.

Bulatović Calasan M, de Vries LD, Vastert SJ, Heijstek MW, Wulffraat NM. Bulatović Calasan M, et al. Rheumatology (Oxford). 2014 Feb;53(2):307-12. doi: 10.1093/rheumatology/ket310. Epub 2013 Oct 24. Rheumatology (Oxford). 2014. PMID: 24162034

10

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients.

Ćalasan MB, den Boer E, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM. Ćalasan MB, et al. Ann Rheum Dis. 2015 Feb;74(2):402-7. doi: 10.1136/annrheumdis-2013-203723. Epub 2013 Nov 28. Ann Rheum Dis. 2015. PMID: 24288013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page